_page-0001.jpg)
.png)
Can the Abbott RealTime hepatitis C virus assay be used to predict therapeutic outcomes in hepatitis C virus-infected patients undergoing triple therapy?
Hiroki Ikeda, Chiaki Okuse, Tsunamasa Watanabe, Nobuyuki Matsumoto, Kotaro Matsunaga, Ryuta Shigefuku, Nobuhiro Hattori, Tetsuya Hiraishi, Yasunobu Fukuda, Yohei Noguchi, Toshiya Ishii, Junko Shima, Kazunari Nakahara, Hiroyuki Yamamoto, Hiroshi Yasuda, Hiroshi Yotsuyanagi, Kazuhiko Koike, Fumio Itoh, Michihiro Suzuki
(Turk J Gastroenterol 2016; 27: 165-172) DOI: 10.5152/tjg.2016.150300